go back

FGFR3 Alteration Test In Bladder Tumors

Vermont rates for HCPCS 0154U

Checks bladder (urothelial) cancer tissue for six alterations in the FGFR3 gene, covering both point mutations in the gene and FGFR3-TACC3 fusion transcripts. FGFR3 changes matter to how the tumor behaves and to treatment planning.

Facilitymedian $479 · 10th–90th $479$8130%20%40%90th$479Professionalmedian $257 · 10th–90th $145$2880%20%40%10th90th$257$100.0$200.0$500.0$1.0K$2.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$144.54
Median
$144.54
Typical High
$257.04
Cigna
Setting
Facility
Modifier
Global
Typical Low
$812.83
Median
$812.83
Typical High
$812.83
Cigna
Setting
Professional
Modifier
Global
Typical Low
$478.63
Median
$478.63
Typical High
$478.63
MVP Health Care
Setting
Facility
Modifier
Global
Typical Low
$478.63
Median
$478.63
Typical High
$478.63
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$478.63
Median
$478.63
Typical High
$478.63
United
Setting
Professional
Modifier
Global
Typical Low
$93.33
Median
$208.93
Typical High
$2,187.76